Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07727993) titled 'Neoadjuvant Propranolol Plus SOX and Toripalimab for Locally Advanced Gastric/GEJ Adenocarcinoma' on July 22.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Ting Liu
Condition:
Gastric or Gastroesophageal Junction Adenocarcinoma
Propranolol
SOX Chemotherapy
Toripalimab
Intervention:
Drug: propranolol
Drug: Toripalimab
Drug: Oxaliplatin
Recruitment Status: Not recruiting
Phase: Phase 1/Phase 2
Date of First Enrollment: August 1, 2026
Target Sample Size: 49
To know more, visit h...